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Abstract
Background: Anaplasmosis is a vectorborne disease caused by the gram-negative bacterium Anaplasma
phagocytophilum. This species displays positive tropism to granulocytes and can cause illness in several mammalian
species, including cats, dogs, and humans. It is considered as an emerging disease in Europe. The clinical signs are
nonspecific and include fever, lethargy, and inappetence. The most typical hematologic abnormality is
thrombocytopenia. A tentative diagnosis can be made by detecting intracytoplasmic morulae inside neutrophils.
The diagnosis is confirmed by PCR and serology in paired serum samples. A sample for PCR analysis should be
taken before treatment. Anaplasmosis is treated with doxycycline.
Case presentation: A feline case of anaplasmosis is presented. The history, clinical presentation, diagnostics,
treatment, and follow-up are discussed.
Conclusions: This case indicates that Anaplasma phagocytophilum infects cats in Finland. To provide accurate
treatment, anaplasmosis should be listed as a differential diagnosis in cats suffering from acute febrile illness with
previous tick exposure.
Background
Anaplasmosis is a vectorborne disease caused by the
gram-negative bacterium Anaplasma phagocytophilum
(encompassing the former Ehrlichia phagocytophila,
Ehrlichia equi, and the human granulocytic ehrlichiosis
agent) [1]. Although anaplasmosis has been known for
decades as a tickborne fever affecting domestic rumi-
nants in Europe [2], A. phagocytophilum can also infect
several other mammalian species, including dogs [3],
horses [4], cats [5], small rodents [6], cervids [6-9],
European bison [2], wild boars, red foxes, European
hares [9], donkeys [10], and humans [11].
The bacterium has been detected in almost all
European countries [2,12]. In Finland A. phagocytophi-
lum infection has previously been reported only in cattle
[13]. This is the first reported case of anaplasmosis in a
cat as well as in any companion animal in Finland.
Case presentation
History
A 3.5-year-old sterilized female Maine coon cat was
brought to the Veterinary Teaching Hospital of Helsinki
University with lethargy and poor appetite in July 2008.
The cat had symptoms for 3 days, including hiding, ocu-
lar discharge, and not drinking, urinating, or defecating
during that period. The symptoms began immediately
after returning from a summer cottage in southeastern
Finland, where the cat was often kept outdoors on a
leash. The owner noticed two ticks attached to the cat’s
skin, 1 day before the appointment. The cat was pre-
viously healthy except for suspected endometriosis trea-
ted with ovariohysterectomy 1 year before.
Clinical presentation
The abnormal findings in the clinical examination were
fever (39.5°C), tachypnea, bilaterally increased lung
sounds, slightly painful cranial abdomen, and discharge
in both eyes. Additionally, the cat had four skin lesions,
indicating previous tick exposure. One Ixodes ricinus
tick was found attached.* Correspondence: helka.heikkila@helsinki.fi
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Diagnostics
Thoracic and abdominal radiographs were obtained.
Venous blood sample was taken into EDTA and heparin
tubes. The complete blood count and biochemistry pro-
file were analyzed. The radiographs showed no abnormal
changes except for minimal bronchial pattern in the
lungs. Lymphopenia (lymphocytes 0.4 × 109/L; reference
range 1.3 - 7.5 × 109/L) and mild hyperglycemia (glucose
7.7 mmol/L; reference range 3.5 - 5.7 mmol/L) were
identified as the only abnormalities in the blood sample.
However, when the blood smear was analyzed, we
detected intracytoplasmic morulae in the neutrophils.
After viewing the morulae, we confirmed the diagnosis of
anaplasmosis by PCR analysis at the laboratory of the
Institute of Comparative Tropical Medicine and Parasi-
tology in Munich, Germany. The sample was tested by a
modified real-time PCR [14] targeting the msp2 gene of
A. phagocytophilum (primers msp25 [5’TTATGAT-
TAGGCCTTTGGGCATG -3’] and msp23 [5’-TCA-
GAAAGATACACGTGCGCCC-3’] [15]). The reaction
was carried out in a BioRad iCycler iQ (BioRad, Munich,
Germany) under cycling conditions comprising an initial
activation (95°C, 15 min), followed by 50 cycles denatura-
tion (94°C, 15 s), and annealing-extension (60°C, 60 s).
DNA of an infected dog and sterile water were used as a
positive and negative control, respectively.
Treatment
Initially, the cat was given subcutaneous injections of
amoxicillin clavulanic acid (14 mg/kg), metoclopramide
(0.4 mg/kg), ranitidine (2.1 mg/kg), meloxicam (0.3 mg/kg),
and subcutaneous fluid therapy with Ringer’s lactate. The
treatment was changed to oral doxycycline (8, 4 mg/kg
twice daily for 30 days) the next day after finding the moru-
lae and with improved appetence of the cat. Percutaneous
fipronil (8.4 mg/kg) was prescribed for once monthly
administration to prevent further tick infestation.
Follow-up
At the control visit 30 days after initiating the treatment,
the owner reported that the cat was clinically healthy.
There were no abnormal findings in clinical examination,
except for tachypnea. A serum biochemistry profile and
complete blood count were obtained. The A. phagocyto-
philum antibody titer was analyzed. No significant hema-
tological or biochemical abnormalities were detected;
lymphocytes were also within the reference range. The
A. phagocytophilum IgG antibody titer was > 1:128. A
titer of 1:32 or more was regarded as positive.
Discussion
Anaplasma phagocytophilum is transmitted by various
ticks, Ixodes ricinus being the vector in Europe [1,12,
16,17]. Transovarial transmission in ticks does not occur
[1,18] and the pathogen is maintained in the environ-
ment by a wide range of hosts such as grazing domestic
ruminants, wild rodents [18], and cervids [19]. There is
some evidence that migratory birds may facilitate the
dispersal of infected ticks to new regions [20]. The pre-
valence of A. phagocytophilum infection has not been
studied in competent reservoir animals or birds in
Finland, but the pathogen was recently found in Ixodes
ricinus ticks from the southeastern part of the country
(E. Hasu, unpublished data). Interestingly, the present
cat had been outdoors in the same region. Anaplasma
phagocytophilum has previously been detected in
ticks in all of the neighboring countries; Estonia [21],
European Russia [16], Sweden [22], and Norway [23].
The clinical manifestation of anaplasmosis varies widely
and is believed to be at least partially host-dependent
[24,25]. In a recent study of experimental anaplasmosis in
sheep, the severity of the clinical manifestation also varied
among different strains of the bacteria [25]. The clinical
signs of anaplasmosis in cats resemble those of the disease
in dogs. In both species the most common manifestation
is an acute febrile illness with lethargy and inappetence
[5,17,24,26], as shown here. The cat also showed other
nonspecific symptoms. Various other symptoms have been
reported in cats, including tachypnea, hyperesthesia, mus-
cle and joint pain, lameness, neck rigidity, lymphadenome-
galy, gingivitis, periodontitis, conjunctivitis, weight loss,
vomiting, pharyngitis, polydipsia, hematuria, and neurolo-
gical problems such as tremors, incoordination, and shy-
ness [27]. Anaplasmosis causes immunosuppression
[27,28], and some of the many symptoms reported in cats
may have been caused by opportunistic infections. The
present cat showed tachypnea with mild bronchial pattern
in the lungs. Tachypnea persisted after treatment and may
have been caused by the stress involved in examination,
since there was no evidence for a pulmonary infection.
The most commonly reported hematologic abnormal-
ity in anaplasmosis is thrombocytopenia [5,17,24,29],
which is assumed to be caused by destruction of the
platelets [30]. Thrombocytopenia is mild to moderate in
cats [5,17] and moderate to severe (< 50 × 109/L) in
dogs [29]. The cat presented here did not have throm-
bocytopenia, but lymphopenia, which is consistent with
previous reports of feline anaplasmosis. Other reported
hematologic abnormalities include neutrophilia with left
shift and anemia. The combination of different hemato-
logical abnormalities varies [5,17,27,28] and is most
probably related to the duration of infection prior to
sampling. Monoclonal gammopathy and hyperglycemia
were reported as serum biochemical abnormalities in
feline anaplasmosis [5,17,24,27,29]. The present cat had
hyperglycemia. As discussed in previous reports, this
was likely attributed to stress. The nonspecific symp-
toms of feline anaplasmosis can resemble a wide range
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of other diseases, including other systemic infections,
immune-mediated diseases, and neoplasia. As in the
present case, a tentative diagnosis of anaplasmosis can
be made by direct microscopic examination of May-
Grünwald-Giemsa-, Wright-, or Romanowsky-stained
peripheral blood smears. The bacterium appears as a
single inclusion with a diameter of 0.54 - 1.3 microns,
or as colonies (morulae) of 1.5 - 5.0 microns in the
cytoplasm of infected neutrophilic and eosinophilic
granulocytes [27,30-32] (Figure 1). In feline experimental
infection with A. phagocytophilum, intracytoplasmic
inclusions appeared in neutrophils in 7 - 9 days [28].
The number of infected cells varies from 1% to 24% in
different reports. The morulae can be detected only
in the acute stage of the disease [5,27], without pre-
treatment with antibiotics [31]. No infected cells were
found in the peripheral blood smear of the present cat
after a 30-day course of doxycycline. In the first
reported feline case of anaplasmosis in Sweden in 1999,
the previously infected cells could no longer be identi-
fied after 15 days of antibiotic therapy [5].
Antibodies against A. phagocytophilum can be examined
by IFA test [17,33], ELISA [10,34], or western immunoblot
assay [35]. In experimentally infected cats, seroconversion
occurred at the earliest within 14 days after infection [28].
At the control visit, the present cat showed positive anti-
body titer despite doxycycline therapy. Various case
reports showed that all cats seroconverted in the course of
the disease and that treatment with antibiotics did not pre-
vent the seroconversion [5,17,36]. Antibody titers can
remain high during the months after infection regardless
of antibiotic treatment [5,17].
Interpretation of serological results can be confusing,
due to seronegativity in the acute stage of the disease,
persisting high antibody titers, and possible cross-
reactivity with antibodies to other ehrlichial bacteria. To
verify the infection by serology only, both acute and
convalescent serum samples should be examined [35].
In humans and dogs, a 4-fold increase in the antibody
titer should be detected in 4 weeks [35,37]. Evaluation
of the evidence for cross-reactivity between A. phagocy-
tophilum and other ehrlichial bacteria in cats is confus-
ing, due to reclassification of the genera in 2001 [1,38].
In cases of feline anaplasmosis in which the diagnosis
was confirmed by PCR, no cross-reactivity was detected
with Ehrlichia canis and Neorickettsia risticii [5,17].
However, although uncommon, cross-reactivity exists in
dogs [39]. Cross-reactivity with antibodies to the more
closely related bacterium Anaplasma platys is likely
[40,41], but there is only limited evidence of feline
A. platys infection [35].
PCR analysis is a direct and reliable method for confirm-
ing the diagnosis in the acute stage of anaplasmosis [42].
The analysis is most often made from peripheral blood
samples, but bone marrow or splenic tissue can also be
used [30]. Samples for PCR analysis should be taken
before treatment [35]. In cats experimentally infected with
A. phagocytophilum, DNA could be detected from blood
and bone marrow from 7 to 11 days after infection [28].
Most of the numerous PCR assays developed for the
detection of A. phagocytophilum use the 16 S rRNA or
the outer surface protein msp2 genes as targets [30].
The sensitivities and specificities vary among the differ-
ent assays and primers; some also detect DNA from
other closely related bacteria [30,43].
Anaplasma phagocytophilum is resistant to various
antibiotics, including beta-lactam and macrolide com-
pounds, sulfonamides, lincosamides, carbapenem anti-
biotics, and aminoglycosides [44-47]. In addition,
its sensitivity to chloramphenicol is poor [44,45,48].
Figure 1 Microscopic evidence for A. phagocytophilum infection in a cat. The arrows in A and B indicate the ehrlichia-like inclusions inside
the neutrophilic granulocytes in a cat with anaplasmosis. The inclusions can appear as single (thick arrow) or as colonies (morulae) in a
cytoplasmic vacuole. Peripheral blood smear, May-Grünwald-Giemsa, original magnification × 1000.
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Tetracyclines, mainly doxycycline, are considered to be
the antibiotics of choice for treatment [39,47]. Rifampin
and fluoroquinolones are effective against A. phagocyto-
philum in vitro [45-47]. Rifampin led to clinical cure in
human anaplasmosis [49,50], while relapse was reported
after fluoroquinolone therapy [51].
Oral doxycycline 10 mg/kg/day for 20 - 30 days and
oral tetracycline 22 mg/kg every 8 h for 21 days can be
used to successfully treat anaplasmosis in cats [5,17].
Doxycycline should be given with water or food to pre-
vent esophageal strictures [52]. If the cat is anorectic,
antibiotic treatment can be started intravenously [5,17],
but phlebitis was reported after intravenous doxycycline
administration [17]. In acute illness the response to
treatment is rapid and seen in 24 - 48 hours [17,39].
The owner of the present cat reported that the symp-
toms resolved in a few days. However, infection may
persist for months despite treatment, and treatment
with tetracyclines, even for 30 days, may not be ade-
quate for elimination of the pathogen in cats. Conver-
sely, complete recovery without antimicrobial treatment
was reported [17]. In murine experimental studies and
in a natural case of human anaplasmosis, previous infec-
tion with A. phagocytophilum did not prevent infection.
However, the clinical course of the disease can be
milder and of shorter duration [53,54].
The prevalence of anaplasmosis is increasing in both
animals and humans [30,55]. The increase may be a
result of several factors, including growing awareness of
vectorborne diseases and how global climate change
affects the distribution and prevalence of reservoir ani-
mals and vectors. Despite the increased prevalence of
anaplasmosis in general, feline anaplasmosis is infre-
quently diagnosed. Although this can partly be related
to the rapid elimination of ticks due to delicate groom-
ing [56], the pathogenicity of tickborne pathogens in
cats requires further research.
Conclusions
This feline case is the first reported A. phagocytophilum
infection in any companion animal in Finland. Ana-
plasma phagocytophilum infection should be considered
as a differential diagnosis in cats suffering from an acute
febrile illness with previous tick exposure.
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